Topics
May/June 2010 | Oncology Feature
Von Hippel-Lindau Disease
A review of the physiopathlology, epidemiology, diagnosis, and treatment for this rare condition.
Hadas Newman, MD, and Paul T. Finger, MD
October 14, 2026
European Trial Finds PRIMA Retinal Implant Demonstrates Sustained Vision Improvement at 3 Years in GA
Cosmetic Products Linked to More than 42,000 Eye Injuries Over 20 Years, Study Finds
October 12, 2026
ANI Pharmaceuticals Reports Sustained 24-Month Efficacy of Iluvien in Phase 4 SYNCHRONICITY Trial
Merck’s Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for DME
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
